Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

385
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
385
Breathing01:05

Breathing

64.0K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

378
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
378
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

446
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
446
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

835
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
835

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols.

The Lancet. Child & adolescent health·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

The Lancet. Child & adolescent health·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial Protocols.

JAMA pediatrics·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 Extension Statement: Enhancing the Reporting and Impact of Pediatric Randomized Trials.

JAMA pediatrics·2026
Same author

CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trials.

BMJ (Clinical research ed.)·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

BMJ (Clinical research ed.)·2026

Related Experiment Videos

Exogenous surfactant therapy: newer developments.

Thierry Lacaze-Masmonteil1

  • 1Service de Pédiatrie et Réanimation Néonatale, Hôpital Antoine-Béclère, Assistance Publique/Hôpitaux de Paris 92141, Clamart, France. tlacaze@club-internet.fr

Seminars in Neonatology : SN
|March 6, 2004
PubMed
Summary

Exogenous surfactant therapy effectively treats neonatal respiratory distress syndrome (RDS). New synthetic surfactants, mimicking natural lung surfactant proteins, show promise for treating RDS and other lung disorders.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Neonatology

Background:

  • Pulmonary surfactant anomalies are linked to various lung conditions.
  • Neonatal Respiratory Distress Syndrome (RDS) in premature infants is primarily caused by surfactant deficiency.
  • Exogenous surfactant therapy has proven efficacy in treating neonatal RDS.

Purpose of the Study:

  • To review the established efficacy of exogenous surfactant for neonatal RDS.
  • To explore the development and potential of novel synthetic surfactants.
  • To highlight the role of surfactant proteins SP-B and SP-C in surfactant function and synthetic design.

Main Methods:

  • Review of clinical studies and meta-analyses on exogenous surfactant therapy.
  • Investigation into the structure-function relationships of surfactant components.
  • Development and clinical trials of new-generation synthetic surfactants.

Main Results:

  • Exogenous surfactant is an established treatment for neonatal RDS.
  • Synthetic surfactants incorporating SP-B and SP-C analogues are under clinical investigation.
  • These novel preparations may offer an alternative to animal-derived surfactants.

Conclusions:

  • Surfactant replacement therapy is crucial for managing neonatal RDS.
  • Advances in understanding surfactant proteins enable the development of synthetic alternatives.
  • Synthetic surfactants hold potential for broader applications in lung disorders.